Diagnosis or presence of asthma within 3 months of the prestudy visit

1. Increase in PEF ≥ 20% or ≥ 60L/min from baseline value after taking Bronchodilator at screening or within the 3 months of the prestudy visit

2. Increase in FEV1 ≥ 12% and ≥ 200mL from baseline value after taking Bronchodilator at screening or within the 3 months of the prestudy visit

FEV1 or PEF between 60% and 85% of the predicted value at screening or within the 3 months of the prestudy visit

Having signed an informed consent

Safety and Efficacy of SA09012 in Asthma